Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Delirium Therapy
Researchers from Tokyo Medical and Dental University report on findings in delirium therapy
March 2nd, 2007
Current study results from the report, "Perospirone in the treatment of patients with delirium," have been published. "Perospirone is a recently developed atypical antipsychotic with potent serotonin 5-HT2 and dopamine D2 antagonist activity. Other atypical antipsychotics including risperidone, quetiapine and olanzapine have been widely used for treatment, not only for schizophrenia symptoms but also for delirium, because of their low potential to induce extrapyramidal disturbances," scientists in Tokyo, Japan report. "In the present study the effectiveness and safety of perospirone in patients with delirium are described. Thirty-eight patients with DSM-IV delirium were...
Source: Drug Week (2007-03-02)
|
